Incannex – Voting Update for Incannex to Redomicile to United States and Trade on Nasdaq Securities Exchange
Highlights: • 99.64% of shareholder voting shares in favour of the share scheme resolution to redomicile, at October 18, 2023… Read more
Incannex – Scheme Booklet Registered with ASIC
Incannex Healthcare Limited (ASX:IHL) (Incannex) refers to its announcement released earlier today regarding: the proposed acquisition of Incannex by Incannex… Read more
Incannex – Court Approves Convening of Meetings to Consider Proposed Schemes
Highlights •The Federal Court of Australia has today made orders for the convening of the Scheme Meetings and approving the… Read more
Incannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD
Melbourne, Australia, August 24, 2023 – Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical… Read more
Incannex – Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed
Melbourne, Australia, August 22, 2023 – Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical… Read more
Incannex to Conduct Shareholder Information Events Regarding Redomicile from Australia to United States
Melbourne, Australia, August 10, 2023 – Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’), is pleased to… Read more
Incannex – Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening
Highlights: • Incannex subsidiary, Clarion Clinics Group Pty Ltd (Clarion) begins accepting registrations of interest in its psychedelic-assisted therapy (PAT)… Read more
Incannex Provides Access to Financial Advisory Firm to Shareholders for Advice Pertaining to Transition from ASX to Nasdaq
Melbourne, Australia, 01 August 2023 – Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL), (‘Incannex’, ‘IHL’ or the ‘Company’) is pleased… Read more
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
Melbourne, Australia, July 28, 2023 – Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or… Read more